We are live on ! Find out more

Mid Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
AMRX icon
26
Amneal Pharmaceuticals
AMRX
$7.02B
$7.02B $20.16 7.75%
BLTE
27
Belite Bio
BLTE
$6.98B
$6.98B $173.40 1.43%
CGON icon
28
CG Oncology
CGON
$6.94B
$6.94B $78.25 4.86%
HIMS icon
29
Hims & Hers Health
HIMS
$6.85B
$6.85B $29.35 4.86%
RYTM icon
30
Rhythm Pharmaceuticals
RYTM
$6.8B
$6.8B $98.83 1.15%
PACS icon
31
PACS Group
PACS
$6.66B
$6.66B $42.06 0.14%
LNTH icon
32
Lantheus
LNTH
$6.55B
$6.55B $100.28 0.27%
CHE icon
33
Chemed
CHE
$6.53B
$6.53B $499.62 0.88%
ORKA
34
Oruka Therapeutics
ORKA
$6.18B
$6.18B $93.38 1.66%
KNSA icon
35
Kiniksa Pharmaceuticals
KNSA
$6.1B
$6.1B $78.13 1.15%
BLCO icon
36
Bausch + Lomb
BLCO
$6B
$6B $16.80 0.3%
MIRM icon
37
Mirum Pharmaceuticals
MIRM
$5.97B
$5.97B $92 0.19%
LQDA icon
38
Liquidia Corp
LQDA
$5.95B
$5.95B $66.43 0.67%
MMED
39
MiniMed Group Inc
MMED
$5.94B
$5.94B $21.12 3.07%
TVTX icon
40
Travere Therapeutics
TVTX
$5.93B
$5.93B $62.86 0.16%
STVN icon
41
Stevanato
STVN
$5.87B
$5.87B $21.51 0.88%
SRRK icon
42
Scholar Rock
SRRK
$5.87B
$5.87B $48.16 3.24%
LGND icon
43
Ligand Pharmaceuticals
LGND
$5.78B
$5.78B $290.07 2.32%
RDNT icon
44
RadNet
RDNT
$5.72B
$5.72B $72.67 4.38%
CRSP icon
45
CRISPR Therapeutics
CRSP
$5.64B
$5.64B $58.33 3.13%
COGT icon
46
Cogent Biosciences
COGT
$5.55B
$5.55B $32 1.59%
PTCT icon
47
PTC Therapeutics
PTCT
$5.45B
$5.45B $65.26 0.17%
DNTH icon
48
Dianthus Therapeutics
DNTH
$5.4B
$5.4B $96.47 0.35%
SHC icon
49
Sotera Health
SHC
$5.34B
$5.34B $18.70 0.16%
TFX icon
50
Teleflex
TFX
$5.29B
$5.29B $124.80 0.22%

Mid Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 168 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $744B.

The largest by market cap are Globus Medical (GMED) at $9.97B, Krystal Biotech (KRYS) at $9.88B and Kymera Therapeutics (KYMR) at $9.78B.

Among institutional investors, Definium Therapeutics (DFTX) drew the most net new fund positions in Q2 2026: 148 funds opened new positions, taking total fund holders up 114 (46%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.